The FDA has approved Zuranolone, a groundbreaking pill for postpartum depression, promising noticeable improvements in as few as three days.
Unlike traditional treatments, Zuranolone directly targets the hormonal shifts post-childbirth, addressing a root cause often overlooked in conventional medicine.
Author: AnnArborPsychiatry
Ann Arbor Psychiatry is a clinic which utilizes a combination of traditional and integrative approaches to mental health treatment. We specialize in the treatment of ADHD, anxiety, depression, and mood swings. Led by Dr. Akash Kumar M.D.
“Peeling Back the Layers of Depression: Are We Asking the Right Questions?
As clinicians and scientists, we’re on the edge of our seats, waiting for this 60-item questionnaire to be available to the broader community. It promises to be a game-changer. It’s not just about providing a diagnosis or a treatment; it’s about empowering our patients with tools for self-assessment, helping them understand and articulate their journey.
The Adderall Shortage: A Reflection on Our Mental Health System
The announcement of the ongoing Adderall shortage last year by the FDA felt like a proverbial lightning bolt in the mental health community. Used for managing attention… Read more “The Adderall Shortage: A Reflection on Our Mental Health System”
Beyond Prescription Medication: The Power of Nutraceuticals in ADHD
While stimulants (combined with talk therapy) are often considered the best treatments for ADHD, the management of attention-deficit/hyperactivity disorder (ADHD) isn’t confined within the walls of prescription medication. An exciting and burgeoning field of research points towards certain supplements and nutraceuticals that show potential in managing this common neurodevelopmental disorder. While the conversation around these alternatives is growing, it’s important to approach it with a clear-eyed understanding of the evidence.
Rewiring the Brain: The Potential of Neuroplasticity in Treating Mental Health Conditions
Can we utilize this inherent neuroplasticity to our advantage in treating mental health conditions?
Research is beginning to say “Yes.” Studies have shown that interventions such as cognitive-behavioral therapy (CBT), mindfulness meditation, and even physical exercise can drive significant changes in the brain circuits related to mood regulation and stress response. What’s even more astounding is the fact that these changes are not just theoretical—they translate to real, noticeable improvements in patients’ symptoms and quality of life.
Procrastination: A Trauma Response
Greetings, this is Dr. Akash Kumar MD writing to briefly touch upon procrastination as a trauma response. In the realms of mainstream psychiatry and therapy, trauma is… Read more “Procrastination: A Trauma Response”
Probiotics: A New Frontier in Depression Treatment
Considering root causes and potential contributing factors can lead to a more nuanced and comprehensive understanding of depression and anxiety.
The Top Ten Common Medications That Can Secretly Contribute To Depression.
These medications, commonly prescribed for nonpsychiatric conditions, have the potential to interact with antidepressants, masking or diluting their effectiveness. This highlights how interconnected our treatments can be.
L-Methylfolate: A Potential Boost to Antidepressant Efficacy
The evidence shows that patients receiving 15 mg/day of LMF for 30 days exhibited significantly greater reduction in Hamilton Depression Rating Scale (HDRS-17) scores and higher response rates compared to the placebo group. Additionally, a 12-month open extension trial indicated that 60% of initial non-responders eventually achieved remission with no serious adverse events.
Unveiling Flavanols: An Underappreciated Ally in Memory Restoration and Executive Functioning?
Flavanols have already been shown to possibly function as anti-obesity agents. Here flavanol intervention restored memory among participants in lower tertiles of habitual diet quality.